Literature DB >> 21857231

Feasibility of a pancreatic cancer surveillance program from a psychological point of view.

Femme Harinck1, Tanja Nagtegaal, Irma Kluijt, Cora Aalfs, Ellen Smets, Jan-Werner Poley, Anja Wagner, Jeanin van Hooft, Paul Fockens, Marco Bruno, Eveline M A Bleiker.   

Abstract

PURPOSE: : The success of any surveillance program depends not solely on its technological aspects but also on the commitment of participants to adhere to follow-up investigations, which is influenced by the psychological impact of surveillance. This study investigates the psychological impact of participating in a pancreatic cancer surveillance program.
METHODS: : High-risk individuals participating in an endoscopic ultrasonography-magnetic resonance imaging-based pancreatic cancer surveillance program received a questionnaire assessing experiences with endoscopic ultrasonography and magnetic resonance imaging, reasons to participate, psychological distress, and benefits and barriers of surveillance. High-risk individuals were individuals with a strong family history of pancreatic cancer or carriers of pancreatic cancer-prone gene mutations.
RESULTS: : Sixty-nine participants (85%) completed the questionnaire. Surveillance was reported as "very to extremely uncomfortable" by 15% for magnetic resonance imaging and 14% for endoscopic ultrasonography. Most reported reason to participate was that pancreatic cancer might be detected in a curable stage. Abnormalities were detected in 27 respondents, resulting in surgical resection in one individual and a shorter follow-up interval in five individuals. Surveillance outcomes did not influence cancer worries. Overall, 29% was "often" or "almost always" concerned about developing cancer. Six respondents (9%) had clinical levels of depression and/or anxiety. According to 88% of respondents, advantages of surveillance outweighed disadvantages.
CONCLUSIONS: : Although endoscopic ultrasonography is more invasive than magnetic resonance imaging, endoscopic ultrasonography was not perceived as more burdensome. Despite one third of respondents worrying frequently about cancer, this was not related to the surveillance outcomes. Anxiety and depression levels were comparable with the general population norms. Advantages of participation outweighed disadvantages according to the majority of respondents. From a psychological point of view, pancreatic cancer surveillance in high-risk individuals is feasible and justified.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21857231     DOI: 10.1097/GIM.0b013e31822934f5

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  15 in total

Review 1.  Familial pancreatic cancer--current knowledge.

Authors:  Detlef K Bartsch; Thomas M Gress; Peter Langer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

2.  Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

Authors:  Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur
Journal:  Radiology       Date:  2014-11-12       Impact factor: 11.105

Review 3.  Familial pancreatic cancer--status quo.

Authors:  Volker Fendrich; Peter Langer; Detlef K Bartsch
Journal:  Int J Colorectal Dis       Date:  2013-08-16       Impact factor: 2.571

4.  Clinical surveillance compared with clinical and magnetic resonance imaging surveillance for brain metastasis: a feasibility survey.

Authors:  K C Y Yiu; J N Greenspoon
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

Review 5.  Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.

Authors:  Laura D Wood; Marcia Irene Canto; Elizabeth M Jaffee; Diane M Simeone
Journal:  Gastroenterology       Date:  2022-04-07       Impact factor: 33.883

Review 6.  Advances in Hereditary Colorectal and Pancreatic Cancers.

Authors:  Meghan L Underhill; Katharine A Germansky; Matthew B Yurgelun
Journal:  Clin Ther       Date:  2016-04-02       Impact factor: 3.393

7.  Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.

Authors:  Carrie X Cao; Jeremy M Sharib; Amie M Blanco; Dena Goldberg; Paige Bracci; Rita A Mukhtar; Laura J Esserman; Kimberly S Kirkwood
Journal:  J Am Coll Surg       Date:  2019-10-28       Impact factor: 6.113

8.  Long-term positive psychological outcomes in an Australian pancreatic cancer screening program.

Authors:  R S O'Neill; B Meiser; S Emmanuel; D B Williams; A Stoita
Journal:  Fam Cancer       Date:  2020-01       Impact factor: 2.375

9.  Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history.

Authors:  Carmen Radecki Breitkopf; Pamela S Sinicrope; Kari G Rabe; Tabetha A Brockman; Christi A Patten; Robert R McWilliams; Shawna Ehlers; Gloria M Petersen
Journal:  Hered Cancer Clin Pract       Date:  2012-06-27       Impact factor: 2.857

10.  The role of endoscopic ultrasound in pancreatic cancer screening.

Authors:  Manoop S Bhutani; Pramoda Koduru; Virendra Joshi; Payal Saxena; Rei Suzuki; Atsushi Irisawa; Kenji Yamao
Journal:  Endosc Ultrasound       Date:  2016 Jan-Feb       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.